Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dai Chihara

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|May 9, 2015
Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in JapanDai Chihara, Naoko Asano, Ken Ohmachi, et al.
Bone Marrow Transplantation|August 12, 2020
Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemiaAyumi Fujimoto, Fumihiro Ishida, Koji Izutsu, et al.
Haematologica|November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphomaAdam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2014
High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective studyDai Chihara, Koji Izutsu, Eisei Kondo, et al.
British Journal of Haematology|June 16, 2016
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trialDai Chihara, Hagop Kantarjian, Susan O'Brien, et al.
Advances in Radiation Oncology|November 9, 2017
Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisionsChelsea C Pinnix, Therese Y Andraos, Bouthaina Dabaja, et al.
Haematologica|March 19, 2026
Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphomaJeremy Ramdial, Erica Agbadiba, Misha Hawkins, et al.
Blood Cancer Journal|September 17, 2021
BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specifiedMario L Marques-Piubelli, Luisa M Solis, Edwin R Parra, et al.
Lancet (London, England)|August 14, 2022
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trialsDai Chihara, Ruitao Lin, Christopher R Flowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2022
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer InstituteDai Chihara, Erich P Huang, Shanda R Finnigan, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|May 9, 2015
Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in JapanDai Chihara, Naoko Asano, Ken Ohmachi, et al.
Bone Marrow Transplantation|August 12, 2020
Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemiaAyumi Fujimoto, Fumihiro Ishida, Koji Izutsu, et al.
Haematologica|November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphomaAdam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2014
High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective studyDai Chihara, Koji Izutsu, Eisei Kondo, et al.
British Journal of Haematology|June 16, 2016
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trialDai Chihara, Hagop Kantarjian, Susan O'Brien, et al.
Advances in Radiation Oncology|November 9, 2017
Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisionsChelsea C Pinnix, Therese Y Andraos, Bouthaina Dabaja, et al.
Haematologica|March 19, 2026
Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphomaJeremy Ramdial, Erica Agbadiba, Misha Hawkins, et al.
Blood Cancer Journal|September 17, 2021
BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specifiedMario L Marques-Piubelli, Luisa M Solis, Edwin R Parra, et al.
Lancet (London, England)|August 14, 2022
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trialsDai Chihara, Ruitao Lin, Christopher R Flowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2022
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer InstituteDai Chihara, Erich P Huang, Shanda R Finnigan, et al.
Pageof 13